ABL Diagnostics Société anonyme (EPA:ABLD)
France · Delayed Price · Currency is EUR 2.500
-0.020 (-0.79%)
Jul 13, 2026, 5:21 PM CET
EPA:ABLD Market Cap
EPA:ABLD has a market cap or net worth of €40.17 million as of July 13, 2026. Its market cap has decreased by -53.83% in one year.
Market Cap
40.17M
Enterprise Value
41.11M
Revenue
7.97M
Ranking
n/a
PE Ratio
41.67
Stock Price
€2.50
Market Cap Chart
Since November 17, 2000, EPA:ABLD's market cap has increased from 2.51M to 40.17M, an increase of 1,501.75%. That is a compound annual growth rate of 11.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 40.17M | -16.90% |
| Dec 31, 2025 | 48.34M | 21.95% |
| Dec 31, 2024 | 39.64M | -74.64% |
| Dec 29, 2023 | 156.30M | 3,819.50% |
| Dec 30, 2021 | 3.99M | 34.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 91.49B |
| EssilorLuxottica Société anonyme | 78.80B |
| Sartorius Stedim Biotech | 17.83B |
| Ipsen | 13.36B |
| MaaT Pharma | 52.39M |
| THX Pharma Société Anonyme | 51.60M |
| Theraclion | 49.86M |
| Fermentalg | 48.03M |